Poehling Capital Management’s UnitedHealth UNH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$3.77M Sell
9,075
-76
-0.8% -$28.2K 0.81% 40
2026
Q1
$2.48M Buy
9,151
+88
+1% +$26.2K 0.52% 55
2025
Q4
$2.99M Buy
9,063
+50
+0.6% +$16.9K 0.61% 45
2025
Q3
$3.11M Buy
+9,013
New +$2.73M 0.65% 43
2022
Q3
Sell
-733
Closed -$376K 129
2022
Q2
$376K Sell
733
-7
-0.9% -$3.52K 0.14% 84
2022
Q1
$377K Buy
740
+190
+35% +$91.6K 0.12% 105
2021
Q4
$276K Hold
550
0.09% 116
2021
Q3
$215K Hold
550
0.07% 128
2021
Q2
$220K Hold
550
0.07% 137
2021
Q1
$205K Buy
+550
New +$191K 0.07% 144
2020
Q3
Sell
-825
Closed -$243K 122
2020
Q2
$243K Sell
825
-45
-5% -$12.9K 0.13% 95
2020
Q1
$217K Sell
870
-25
-3% -$6.88K 0.16% 84
2019
Q4
$263K Buy
+895
New +$234K 0.17% 92
2019
Q3
Sell
-845
Closed -$206K 107
2019
Q2
$206K Buy
+845
New +$203K 0.14% 99
2018
Q3
Sell
-645
Closed -$158K 246
2018
Q2
$158K Hold
645
0.14% 101
2018
Q1
$138K Buy
645
+95
+17% +$21.7K 0.11% 103
2017
Q4
$121K Buy
+550
New +$117K 0.1% 105

Other funds holding UNH

Poehling Capital Management's UNH Position: Q2 2026 in Review

Poehling Capital Management reduced its UnitedHealth (UNH) stake by 0.83% in Q2 2026, selling an estimated $28.2K and leaving 9,075 shares worth $3.77M. The position accounts for 0.81% of the portfolio, ranked #40.

Poehling Capital Management first reported a position in UNH in Q4 2017 and has held it in 17 quarters since. 1,733 funds tracked by Wall St. Rank hold UNH as of Q2 2026.

  • Poehling Capital Management held 9,075 shares of UnitedHealth worth $3.77M as of Q2 2026.
  • Poehling Capital Management sold 76 UnitedHealth shares in Q2 2026, an estimated $28.2K.
  • UnitedHealth made up 0.81% of Poehling Capital Management's portfolio in Q2 2026, its #40 holding.
  • Poehling Capital Management first reported a position in UnitedHealth in Q4 2017 and has held it in 17 quarters since.
  • 1,733 funds tracked by Wall St. Rank held UnitedHealth as of Q2 2026.

Based on Poehling Capital Management's 13F filing for Q2 2026, filed 20 Jul 2026.